219.55MMarket Cap-1093P/E (TTM)
19.240High16.351Low466.12KVolume18.440Open17.120Pre Close8.24MTurnover9.61%Turnover RatioLossP/E (Static)12.27MShares23.00052wk High14.32P/B86.80MFloat Cap3.72052wk Low--Dividend TTM4.85MShs Float1038.000Historical High--Div YieldTTM16.88%Amplitude3.720Historical Low17.673Avg Price1Lot Size
Arqit Quantum Stock Forum
H.C. Wainwright adjusted the firm's price target on Arqit Quantum (ARQQ) to $22 from $2 and keeps a Buy rating on the shares to reflect the recent reverse share split.
The firm believes the upcoming second half of 2024 results could be a potential catalyst for the shares.
Gapping up
$Poseida Therapeutics (PSTX.US)$' stock jumped over 200%. This happened because Roche, a Swiss company, is buying Poseida for up to $1.5 billion in cash.
Shares of weight-loss drug maker $Novo-Nordisk A/S (NVO.US)$ and $Eli Lilly and Co (LLY.US)$ rose 2.1% and 4.9% respectively on Tuesday as U.S. President Jo Biden proposed expanding coverage of anti-obesity drugs for millions on Medicare and Medicaid...
Deutsche Bank's Chief Global Strategist, Binky Chadha, has put fort...
No comment yet